Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Influenza A Neuraminidase Protein (N2) (N2)
- Target
- N2
- Molecular classification
- Enzyme, Viral protein, Glycoprotein
01
Overview
The influenza A neuraminidase (NA) protein, specifically the N2 subtype, is a surface glycoprotein and one of the major antigens of the influenza A virus. It plays a crucial role in viral replication and spread by cleaving sialic acid residues from host cell receptors and newly formed viral glycoproteins.
02
Mechanism of action
Neuraminidase inhibition
03
Biological functions
Viral replicationViral releaseSialic acid cleavage
04
Disease associations
Infection
05
Safety considerations
Drug resistance
06
Interacting drugs
Oseltamivir
Beyond the preview
Go deeper on Influenza A Neuraminidase Protein (N2) (N2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Influenza A Neuraminidase Protein (N2) (N2).